LABORATORY RESEARCH A MicroRNA Code for Prostate Cancer Metastasis Investigators showed that loss of miR-15 and miR-16 in cooperation with increased miR-21 expression promote prostate cancer spreading and bone lesions. This combination of microRNAs endows bone-metastatic potential to prostate cancer cells. [Oncogene] Full Article CRISPR/Cas9-Mediated Gene Knockout of NANOG and NANOGP8 Decreases the Malignant Potential of Prostate Cancer Cells Investigators established NANOG and NANOGP8-knockout DU145 prostate cancer cell lines using the CRISPR/Cas9 system. Knockouts of NANOG and NANOGP8 significantly attenuated malignant potential, including sphere formation, anchorage-independent growth, migration capability, and drug resistance, compared to parental DU145 cells. [Oncotarget] Full Article Hypoxia Induces Triglycerides Accumulation in Prostate Cancer Cells and Extracellular Vesicles Supporting Growth and Invasiveness following Reoxygenation Researchers report that under hypoxia, human prostate cancer cells, and extracellular vesicles released by these cells, are significantly enriched in triglycerides due to the activation of lipogenesis-related enzymes and signaling molecules. [Oncotarget] Full Article GLIPR1-ΔTM Synergizes with Docetaxel in Cell Death and Suppresses Resistance to Docetaxel in Prostate Cancer Cells Scientists evaluated the hypothesis that the combination treatment with docetaxel and GLIPR1-ΔTM will synergistically induce greater cell death and inhibit the emergence of resistance and development of metastatic potential in prostate cancer cells. [Mol Cancer] Abstract | Full Article Development of Novel Radio-Chemotherapy Approaches Targeting Prostate Tumor Progenitor Cells Using Nanohybrids Researchers describe the synthesis of biocompatible, catechin-loaded and gelatin-conjugated carbon nanotubes with anticancer properties and demonstrated their potential for the eradication of prostate cancer stem cells in combination with X-ray irradiation. [Int J Cancer] Abstract Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts Scientists investigated the ability of Pim kinases to promote metastatic growth of prostate cancer cells in two xenograft models for human prostate cancer. They also evaluated the efficacy of Pim-selective inhibitors to antagonize these effects. [PLoS One] Full Article Oncolytic Virus Carrying shRNA Targeting SATB1 Inhibits Prostate Cancer Growth and Metastasis The authors constructed ZD55-SATB1, an oncolytic adenovirus ZD55 carrying shRNA targeting SATB1, and investigated its effects on the inhibition of prostate cancer growth and metastasis. ZD55-SATB1 was constructed and used to infect human prostate cancer cell lines DU145 and LNCaP. [Tumor Biol] Abstract Metformin Induces ER Stress-Dependent Apoptosis through miR-708-5p/NNAT Pathway in Prostate Cancer Scientists identified miR-708-5p as a novel target of metformin in prostate cancer cells. Metformin promotes increased expression of miR-708-5p, leading to suppression of endoplasmic reticulum (ER) membrane protein neuronatin expression and subsequently induces apoptosis of prostate cancer cells through the ER stress pathway. [Oncogenesis] Full Article CLINICAL RESEARCH A Randomized Non-Comparative Phase II Trial of Cixutumumab (IMC-A12) or Ramucirumab (IMC-1121B) plus Mitoxantrone and Prednisone in Men with Metastatic Docetaxel-Pretreated Castration-Resistant Prostate Cancer A non-comparative randomized Phase II study evaluated cixutumumab or ramucirumab plus mitoxantrone and prednisone in metastatic castration-resistant prostate cancer. [Eur J Cancer] Abstract Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer Scientists investigated whether AR-V7–positive patients would retain sensitivity to taxane chemotherapy and whether AR-V7 status would have a differential impact on taxane-treated men compared with enzalutamide- or abiraterone-treated men. [JAMA Oncol] Full Article | Press Release |